This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Teresa Sharav, MBBS, MPH; Heddy Landau, MD; Zvi Zadik, MD; Thomas R. Einarson, PhD

Am J Dis Child. 1991;145(2):172-175.

Abstract
• Thyroid function in subjects with Down syndrome was studied using the thyrotropin-releasing hormone test. Forty-seven infants and children with Down syndrome were investigated. Ages ranged from 1 month to 7 years; there were 26 boys and 21 girls. Fourteen of the subjects with Down syndrome who had an exaggerated thyroid-stimulating hormone response to thyrotropin-releasing hormone stimulation had two or more annual follow-up tests. The remaining 33 subjects who only underwent one thyrotropin-releasing hormone test were compared with 22 age-matched controls (11 boys and 11 girls). Mean basal thyroxine 4 and triiodothyronine 3 values were in the normal ranges. All thyroid antibody titers were negative. Mean basal thyroid-stimulating hormone levels of subjects with Down syndrome were significantly higher than those of controls for all ages, even though there was a decline in thyroid-stimulating hormone levels in both groups. Peak thyroid-stimulating hormone response levels were significantly greater in the subjects with Down syndrome than in the controls. Longitudinal study of the 14 children with Down syndrome with an exaggerated thyroid-stimulating hormone response showed that the response remained exaggerated until the third year of life, when it declined to normal levels. Thyroid dysfunction during the growth spurt of infancy or delayed maturation of the hypothalamic pituitary thyroid axis are proposed mechanisms.

(AJDC. 1991;145:172–175)

Author Affiliations
From the Jerusalem (Israel) Child Development Center (Dr Sharav); the Department of Pediatrics and Clinical Endocrinology, Hadassah University Hospital, Jerusalem (Dr Landau); the Department of Pediatric Endocrinology, Kaplan Hospital, Rehovot, Israel (Dr Zadik); and the Faculty of Pharmacy and Department of Health Administration, Faculty of Medicine, University of Toronto, Ontario (Dr Einarson).

Footnotes
Accepted for publication May 18, 1990.

Reprint requests to the Jerusalem Child Development Center, 24 Strauss St, Jerusalem, Israel 95142 (Dr Sharav).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns
van Trotsenburg et al.
J. Clin. Endocrinol. Metab. 2003;88:1512-1515.
ABSTRACT | FULL TEXT